Southwest Pediatric Device Consortium


The Southwest National Pediatric Device Consortium (SWPDC), anchored by Texas Children’s Hospital and Baylor College of Medicine, supports pediatric device innovators with product and technology acceleration services and business acceleration services both regionally and nationally, with the goal of commercialization and clinical use of novel pediatric medical devices. 

Learn more


  • Develop and implement strategies that will sustain a productive needs-driven pipeline of new pediatric devices
  • Optimize the regulatory and manufacturing infrastructure within Texas Children's Hospital/Baylor College of Medicine, Texas Medical Center-affiliated institutions, and the Southwest U.S. region in order to enable pediatric device projects at all stages to progress toward commercialization and clinical implementation
  • Serve as a resource both in the Southwest U.S., as well as national and internationally, for pediatric device development

Learn about SWPDC's long-term goals


The consortium includes clinical, scientific, business, financial, regulatory, reimbursement, engineering, ISO13485 compliant product design & manufacturing, intellectual property, and academic partners {Texas Children's Hospital/Baylor College of Medicine (Drs. Chester Koh and Henri Justino), Texas A&M University System (Dr. Balakrishna Haridas), Rice University (Dr. Eric Richardson), University of Houston (Dr. Richard Willson), Fannin Innovation Studios (Dr. Heffernan), Biotex (Dr. Gowda), and more} in the Houston / Southwest U.S. region, including Texas A&M University, Rice University, University of Houston, local device development firms, and other children’s hospitals in the Southwest U.S. region (including Children's Hospital of San Antonio, Children's Health in Dallas, and Phoenix Children's). 

Learn more


SWPDC recently received a prestigious P50 grant from the U.S. Food & Drug Administration (FDA). They were selected to receive the five-year, $6.75M grant as one of five national consortia that are addressing the shortage of pediatric devices. With the P50 grant support, SWPDC will leverage its ongoing activities to expand its footprint to accelerate the development of much-needed medical devices.SWPDC will provide services in several areas: unmet needs assessment, prototype development, product and technology acceleration services, and business acceleration services. 

The SWPDC members will evaluate and support projects, as well as advise innovators throughout the total product life cycle. Based on individual project needs, the consortium will direct investigators to specific resources, collaborators and industry experts, and will coordinate the services offered by its member programs to identify, evaluate and assist pediatric device projects.  

Additional work within the consortium involves a Real World Evidence (RWE) demonstration project with Texas Children’s and Texas A&M University that builds upon the work of the PATHS-UP Engineering Research Center led by Texas A&M. PATHS-UP is supported by a 10-year, $40M National Science Foundation grant. Advanced patient care algorithms and novel devices will be developed for improved continuous glucose monitoring in children with diabetes to avoid the complications associated with inadequate glucose control.

Current device projects:

  • Polyvascular - pediatric polymeric pulmonary valve  (STTR Phase 1 funding - NHLBI - R41HL129577) 
  • Stent-X - magnetic ureteral stent removal device for children (SBIR Phase I funding - NIDDK - R43DK115336)
  • Vaginal stent device for children (SBIR Phase I funding - NICHD - 1R43 HD092156)